邻苯二甲酸二异癸酯结构式
|
常用名 | 邻苯二甲酸二异癸酯 | 英文名 | Reomol DiDP |
|---|---|---|---|---|
| CAS号 | 26761-40-0 | 分子量 | 446.662 | |
| 密度 | 1.0±0.1 g/cm3 | 沸点 | 425.8±13.0 °C at 760 mmHg | |
| 分子式 | C28H46O4 | 熔点 | 235ºC | |
| MSDS | 中文版 美版 | 闪点 | 227.6±9.3 °C | |
| 符号 |
GHS09 |
信号词 | Warning |
邻苯二甲酸二异癸酯用途【用途一】 用作色谱固定液。 |
| 中文名 | 邻苯二甲酸二异癸酯 |
|---|---|
| 英文名 | Bis(8-methylnonyl) phthalate |
| 中文别名 | 1,2-苯二甲酸二异癸酯 | 1,2-苯二甲酸二异癸酯,酞酸二异癸酯 | 邻酞酸二异癸酯 |
| 英文别名 | 更多 |
| 密度 | 1.0±0.1 g/cm3 |
|---|---|
| 沸点 | 425.8±13.0 °C at 760 mmHg |
| 熔点 | 235ºC |
| 分子式 | C28H46O4 |
| 分子量 | 446.662 |
| 闪点 | 227.6±9.3 °C |
| 精确质量 | 446.339600 |
| PSA | 52.60000 |
| LogP | 10.83 |
| InChIKey | ZVFDTKUVRCTHQE-UHFFFAOYSA-N |
| SMILES | CC(C)CCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC(C)C |
| 外观性状 | 无色液体 |
| 蒸汽压 | 0.0±1.0 mmHg at 25°C |
| 折射率 | 1.487 |
| 储存条件 | 密封保存。 |
| 水溶解性 | 水溶性:不溶;水溶解度:0.28 mg/l 24 °C |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:0 3.氢键受体数量:4 4.可旋转化学键数量:20 5.互变异构体数量:无 6.拓扑分子极性表面积52.6 7.重原子数量:32 8.表面电荷:0 9.复杂度:442 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1.性状:无色液体 2.熔点:235 ℃ 3.闪点:122 ℃ 4.密度:0.965 g/mL at 20 ℃ 5.溶解性:溶于醇、酮、醚、酯类、脂烃、芳烃及卤代烃,不溶于甘油、二醇类和某些胺类。在水中的溶解度小于0.01%(25℃)。 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 海关编码 | 2917349000 |
|---|---|
| 中文概述 | 2917349000 其他邻苯二甲酸酯。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 对苯二甲酸请注明4-CBA值, 对苯二甲酸请注明P-TL酸值, 对苯二甲酸请注明色度, 对苯二甲酸请注明水分 |
| Summary | 2917349000 other esters of orthophthalic acid。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
|
Effects of endocrine disruptors on dehydroepiandrosterone sulfotransferase and enzymes involved in PAPS synthesis: genomic and nongenomic pathways.
Environ. Health Perspect. 115 Suppl 1 , 51-4, (2007) Sulfation plays an important role both in detoxification and in the control of steroid activity. Studies in rodents have shown that the conversion of dehydroepiandrosterone (DHEA) to DHEA-sulfate is i... |
|
|
Adjuvant effect of di-n-butyl-, di-n-octyl-, di-iso-nonyl- and di-iso-decyl phthalate in a subcutaneous injection model using BALB/c mice.
Pharmacol. Toxicol. 91(5) , 264-72, (2002) During the last decades, the prevalence of the allergic airway diseases, asthma and rhinitis, has increased world-wide. Introduction of environmental chemicals with adjuvant effect may play a role in ... |
|
|
Effects of phthalates on the human corneal endothelial cell line B4G12.
Int. J. Toxicol. 31(4) , 364-71, (2012) Phthalates are industrial chemicals used in many cosmetics. We evaluated an in vitro model for eye irritancy testing using the human corneal endothelial cell line B4G12. Cell proliferation and toxicit... |
| Bisisocyanide |
| EINECS 247-977-1 |
| Isodecyl Alcohol Phthalate (2:1) |
| di-iso-decyl phthalate |
| 1,2-Benzenedicarboxylic acid diisodecyl ester |
| bis(8-methylnonyl) benzene-1,2-dicarboxylate |
| Plasthall DIDP |
| Diisodecyl Phthalate |
| Bis(8-methylnonyl) phthalate |
| Di-isodecyl phthalate |
| Reomol DiDP |
| 1,2-Benzenedicarboxylic acid, bis(8-methylnonyl) ester |
| Jayflex DIDP |
| 15,16-dihydrocyclopenta<a>phenanthren-3,4,17-trione 17-methoxime |
| Sansocizer DIDP |
| diisocyanogen |
| Phthalic Acid Diisodecyl Ester |
| MFCD00048389 |
| ISODECYL PHTHALATE |
| Phthalic Acid Bis(8-methylnonyl) Ester |
| 15,16-Seco-serratan-15,16-disaeure-dimethylester |
| Hexaplas DIDP |